Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 83,908,968
- Share change
- -1,368,165
- Total reported value
- $1,249,338,646
- Put/Call ratio
- 48%
- Price per share
- $14.89
- Number of holders
- 185
- Value change
- -$21,214,675
- Number of buys
- 74
- Number of sells
- 90
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
7.9%
|
9,732,399
|
$148,808,381 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
5,468,755
|
$83,617,263 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
3.6%
|
4,467,557
|
$68,308,948 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.8%
|
3,478,440
|
$53,185,348 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
3,011,174
|
$46,040,850 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2%
|
2,437,073
|
$37,262,846 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
1.3%
|
1,612,077
|
$24,648,657 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,602,200
|
$24,497,638 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
1,523,951
|
$23,301,484 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
1,319,266
|
$20,171,569 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.1%
|
1,300,954
|
$19,891,587 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,222,206
|
$18,691,668 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.84%
|
1,025,754
|
$15,683,779 | — | 30 Sep 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.76%
|
931,048
|
$14,236,000 | — | 30 Sep 2024 | |
| Decheng Capital LLC |
13F
|
Company |
0.71%
|
869,790
|
$13,299,089 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.61%
|
744,000
|
$11,375,760 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
714,456
|
$10,924,033 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.57%
|
703,336
|
$10,754,007 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.55%
|
673,838
|
$10,302,981 | — | 30 Sep 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
663,603
|
$10,146,490 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
566,979
|
$8,669,109 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
509,918
|
$7,796,646 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.31%
|
379,100
|
$5,796,000 | — | 30 Sep 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.29%
|
357,838
|
$5,471,343 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
351,325
|
$5,371,759 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
317,871
|
$4,860,248 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.21%
|
256,717
|
$3,925,203 | — | 30 Sep 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.21%
|
255,611
|
$3,908,292 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
245,102
|
$3,747,610 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.19%
|
238,544
|
$3,647,338 | — | 30 Sep 2024 | |
| AXA S.A. |
13F
|
Company |
0.19%
|
232,266
|
$3,551,347 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
226,571
|
$3,464,271 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
217,041
|
$3,318,556 | — | 30 Sep 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.17%
|
213,684
|
$3,305,692 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.15%
|
187,415
|
$2,866,000 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
183,900
|
$2,811,831 | — | 30 Sep 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.14%
|
175,000
|
$2,675,750 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
169,853
|
$2,597,052 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.14%
|
168,082
|
$2,569,973 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.13%
|
161,835
|
$2,474,437 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.13%
|
158,033
|
$2,416,325 | — | 30 Sep 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.13%
|
153,783
|
$2,351,342 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.12%
|
146,974
|
$2,247,233 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
140,913
|
$2,154,559 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
135,659
|
$2,074,226 | — | 30 Sep 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.1%
|
126,386
|
$1,932,444 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
118,693
|
$1,814,816 | — | 30 Sep 2024 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.09%
|
114,399
|
$1,749,161 | — | 30 Sep 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
112,829
|
$1,725,155 | — | 30 Sep 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.09%
|
112,847
|
$1,725,000 | — | 30 Sep 2024 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q4 2024
As of 31 Dec 2024,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,908,968 shares.
The largest 10 holders included
GILEAD SCIENCES, INC., BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, Woodline Partners LP, STATE STREET CORP, Point72 Asset Management, L.P., DIMENSIONAL FUND ADVISORS LP, Siren, L.L.C., and Boxer Capital Management, LLC.
This page lists
186
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
184
Q4 2024 holders
185
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.